About Zivo Bioscience
Zivo Bioscience is a company based in Keego Harbor (United States) founded in 1983. Zivo Bioscience has raised $962 thousand across 20 funding rounds from investors including Health Enterprise Partners. The company has 7 employees as of December 31, 2024. Zivo Bioscience offers products and services including Algal Biomass Extract and Bioactive Compounds. Zivo Bioscience operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Keego Harbor, United States
- Employees 7 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zivo Bioscience, Inc.
-
Annual Revenue
$157.22 K (USD)468.61as on Dec 31, 2024
-
Net Profit
-$13.38 M (USD)-72.1as on Dec 31, 2024
-
EBITDA
-$13.36 M (USD)-83.97as on Dec 31, 2024
-
Total Equity Funding
$962 K (USD)
in 20 rounds
-
Latest Funding Round
$4 M (USD), Post-IPO
Jun 30, 2023
- Investors
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zivo Bioscience
Zivo Bioscience is a publicly listed company on the OTC with ticker symbol ZIVO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zivo Bioscience
Zivo Bioscience offers a comprehensive portfolio of products and services, including Algal Biomass Extract and Bioactive Compounds.
Extract for enhancing immune response in animals and human health.
Compounds supporting muscle recovery and joint health in humans.
People of Zivo Bioscience
Unlock access to complete
Leadership Team
3 people
Product Management Team
2 people
Finance and Accounting
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Zivo Bioscience
Zivo Bioscience has successfully raised a total of $962K across 20 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zivo Bioscience
Zivo Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Health Enterprise Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on healthcare and information technology sectors.
|
Locked | Locked | Locked |
Investor details for Zivo Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zivo Bioscience
Investment portfolio details for Zivo Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zivo Bioscience
Detailed financials for Zivo Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zivo Bioscience Comparisons
Peer comparison for Zivo Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zivo Bioscience
Zivo Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Zivo Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zivo Bioscience
Complete news archive for Zivo Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zivo Bioscience
Zivo Bioscience was founded in 1983 and raised its 1st funding round 26 years after it was founded.
Zivo Bioscience is headquartered in Keego Harbor, United States. It is registered at Keego Harbor, Michigan, United States.
Zivo Bioscience is a funded company, having raised a total of $962K across 20 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Zivo Bioscience is 7.
Annual revenue of Zivo Bioscience is $157.22K as on Dec 31, 2024.
Zivo Bioscience was founded in 1983 in Keego Harbor, United States, within the biotechnology sector. A patented platform is utilized for extracting bioactive molecules from algal biomass. Byproduct extracts are combined with other ingredients to produce supplements and food items, while high-value components such as nutrients and proteins are isolated. Initial market entry is targeted at nutritional products, followed by expansion into pharmaceuticals and medicinal applications.
Zivo Bioscience's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Zivo Bioscience offers Algal Biomass Extract and Bioactive Compounds.
Yes, Zivo Bioscience is publicly traded on OTC under the ticker symbol ZIVO.
Zivo Bioscience has 1 investor. Key investors include Health Enterprise Partners.
The ticker symbol of Zivo Bioscience is ZIVO on OTC.